HIT Consultant January 20, 2025
Jasmine Pennic

What You Should Know:

– The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade.

– Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years.

Insulin Costs Plummet: A Decade-Long High Comes to an End

The struggle to afford insulin has been a major challenge for many people with diabetes, forcing some to ration their medication or even skip doses altogether. But recent policy changes and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Pharma Pulse 1/20/25: Leveraging Data Standards, The Good and Bad News About Melanoma & more
What’s Driving Pharma Investors in 2025
STAT+: AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
PBMs Under Fire Again, But Despite Bipartisan Pressure Reforms May Be Elusive
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA

Share This Article